A new review published in The Lancet medical journal claims that at least a million more people in the UK should be put on antidepressant drugs.
Notably, in its publicizing of this story, the mass media failed to mention that one of the scientists who conceived and designed the review has received lecture fees from the drug companies Eli Lilly, Janssen, Meiji, Mitsubishi-Tanabe, Merck Sharp & Dohme, and Pfizer; as well as research support from Mochida and Mitsubishi-Tanabe. This scientist also assisted in selecting the studies analyzed, extracting the data, and writing the first draft of the manuscript.
Another scientist involved in the review has received honoraria for consulting from LB Pharma, Lundbeck, Otsuka, TEVA, Geodon Richter, Recordati, LTS Lohmann, and Boehringer Ingelheim; and for lectures from Janssen, Lilly, Lundbeck, Otsuka, SanofiAventis, and Servier. Moreover, at least two futher scientists involved in the review have similarly received lecture fees from drug companies.
What this review and the media’s reports on it additionally fail to mention is that supplementation with nutrients such as B vitamins, magnesium, and omega-3 has been shown in scientific studies to be effective in improving depression outcomes. With studies also showing that our psychological wellbeing is closely linked to the food we consume in our daily diets, the old adage ‘we are what we eat’ can thus be seen to apply just as much to our mental health as it does to our physical wellbeing.